Europe Medical Exoskeleton Market to 2031 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Medical Exoskeleton Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Medical Exoskeleton Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Rising Number of Strategic Initiatives

5.2 Market Opportunities

5.2.1 Increasing Prevalence of SCI

5.3 Future Trends

5.3.1 Growing Incidence of Stroke and Musculoskeletal

5.4 Impact of Drivers and Restraints

6. Europe Medical Exoskeleton Market Regional Analysis

6.1 Europe Medical Exoskeleton Market Overview

6.2 Europe Medical Exoskeleton Market Revenue 2020-2031 (US$ Million)

6.3 Europe Medical Exoskeleton Market Forecast Analysis

7. Europe Medical Exoskeleton Market Analysis – by Component

7.1 Hardware

7.1.1 Overview
7.1.2 Hardware: Europe Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Software

7.2.1 Overview
7.2.2 Software: Europe Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Medical Exoskeleton Market Analysis – by Type

8.1 Powered Exoskeleton

8.1.1 Overview
8.1.2 Powered Exoskeleton: Europe Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

8.2 Passive Exoskeleton

8.2.1 Overview
8.2.2 Passive Exoskeleton: Europe Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

9. Europe Medical Exoskeleton Market Analysis – by Extremity

9.1 Lower Body Exoskeleton

9.1.1 Overview
9.1.2 Passive Exoskeleton: Europe Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

9.2 Upper Body Exoskeleton

9.2.1 Overview
9.2.2 Passive Exoskeleton: Europe Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

9.3 Full Body Exoskeleton

9.3.1 Overview
9.3.2 Passive Exoskeleton: Europe Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

10. Europe Medical Exoskeleton Market – Europe Analysis

10.1 Europe

10.1.1 Europe Medical Exoskeleton Market Breakdown, by Key Country, 2023 and 2031 (%)
10.1.1.1 Europe Medical Exoskeleton Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.1.1 UK: Europe Medical Exoskeleton Market Breakdown, by Component
10.1.1.1.2 UK: Europe Medical Exoskeleton Market Breakdown, by Type
10.1.1.1.3 UK: Europe Medical Exoskeleton Market Breakdown, by Extremity

10.1.1.2 Germany: Europe Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.2.1 Germany: Europe Medical Exoskeleton Market Breakdown, by Component
10.1.1.2.2 Germany: Europe Medical Exoskeleton Market Breakdown, by Type
10.1.1.2.3 Germany: Europe Medical Exoskeleton Market Breakdown, by Extremity

10.1.1.3 France: Europe Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.3.1 France: Europe Medical Exoskeleton Market Breakdown, by Component
10.1.1.3.2 France: Europe Medical Exoskeleton Market Breakdown, by Type
10.1.1.3.3 France: Europe Medical Exoskeleton Market Breakdown, by Extremity

10.1.1.4 Russia: Europe Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.4.1 Russia: Europe Medical Exoskeleton Market Breakdown, by Component
10.1.1.4.2 Russia: Europe Medical Exoskeleton Market Breakdown, by Type
10.1.1.4.3 Russia: Europe Medical Exoskeleton Market Breakdown, by Extremity

10.1.1.5 Italy: Europe Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.5.1 Italy: Europe Medical Exoskeleton Market Breakdown, by Component
10.1.1.5.2 Italy: Europe Medical Exoskeleton Market Breakdown, by Type
10.1.1.5.3 Italy: Europe Medical Exoskeleton Market Breakdown, by Extremity

10.1.1.6 Rest of Europe: Europe Medical Exoskeleton Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Medical Exoskeleton Market Breakdown, by Component
10.1.1.6.2 Rest of Europe: Europe Medical Exoskeleton Market Breakdown, by Type
10.1.1.6.3 Rest of Europe: Europe Medical Exoskeleton Market Breakdown, by Extremity

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Medical Exoskeleton Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Ekso Bionics Holdings Inc\r\n

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Lifeward, Inc\r\n

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 ExoAtlet\r\n

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Cyberdyne Inc\r\n

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 BIONIK\r\n

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 B-Temia Inc\r\n

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Hocoma AG\r\n

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Wearable Robotics SRL\r\n

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Myomo Inc\r\n

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Rex Bionics Ltd.

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights